These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10736302)
1. Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Jung WI; Hoess T; Bunse M; Widmaier S; Sieverding L; Breuer J; Apitz J; Schmidt O; van Erckelens F; Dietze GJ; Lutz O Circulation; 2000 Mar; 101(12):E121. PubMed ID: 10736302 [No Abstract] [Full Text] [Related]
2. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. Crilley JG; Boehm EA; Blair E; Rajagopalan B; Blamire AM; Styles P; McKenna WJ; Ostman-Smith I; Clarke K; Watkins H J Am Coll Cardiol; 2003 May; 41(10):1776-82. PubMed ID: 12767664 [TBL] [Abstract][Full Text] [Related]
3. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. Spindler M; Saupe KW; Christe ME; Sweeney HL; Seidman CE; Seidman JG; Ingwall JS J Clin Invest; 1998 Apr; 101(8):1775-83. PubMed ID: 9541509 [TBL] [Abstract][Full Text] [Related]
4. Novel cardiac beta-myosin heavy chain gene missense mutations (R869C and R870C) that cause familial hypertrophic cardiomyopathy. Anan R; Shono H; Tei C Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862102 [No Abstract] [Full Text] [Related]
5. Can an energy-deficient heart grow bigger and stronger? Roberts R; Marian AJ J Am Coll Cardiol; 2003 May; 41(10):1783-5. PubMed ID: 12767665 [No Abstract] [Full Text] [Related]
8. Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy. Abraham MR; Bottomley PA; Dimaano VL; Pinheiro A; Steinberg A; Traill TA; Abraham TP; Weiss RG Am J Cardiol; 2013 Sep; 112(6):861-6. PubMed ID: 23751935 [TBL] [Abstract][Full Text] [Related]
9. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain. Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202 [TBL] [Abstract][Full Text] [Related]
10. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy. Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830 [TBL] [Abstract][Full Text] [Related]
11. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417 [TBL] [Abstract][Full Text] [Related]
12. The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age. Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M Am J Cardiol; 2001 Jun; 87(11):1315-7. PubMed ID: 11377367 [No Abstract] [Full Text] [Related]
13. Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice. Welikson RE; Buck SH; Patel JR; Moss RL; Vikstrom KL; Factor SM; Miyata S; Weinberger HD; Leinwand LA Am J Physiol; 1999 Jun; 276(6):H2148-58. PubMed ID: 10362699 [TBL] [Abstract][Full Text] [Related]
14. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy. Sieverding L; Jung WI; Breuer J; Widmaier S; Staubert A; van Erckelens F; Schmidt O; Bunse M; Hoess T; Lutz O; Dietze GJ; Apitz J Am J Cardiol; 1997 Aug; 80(3A):34A-40A. PubMed ID: 9293954 [TBL] [Abstract][Full Text] [Related]
15. Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. Ashrafian H; Redwood C; Blair E; Watkins H Trends Genet; 2003 May; 19(5):263-8. PubMed ID: 12711218 [TBL] [Abstract][Full Text] [Related]
16. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. Javadpour MM; Tardiff JC; Pinz I; Ingwall JS J Clin Invest; 2003 Sep; 112(5):768-75. PubMed ID: 12952925 [TBL] [Abstract][Full Text] [Related]
17. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children. Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230 [TBL] [Abstract][Full Text] [Related]
18. [Phenotype variation of familial hypertrophic cardiomyopathy caused by combined missense mutations]. Arai S Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 Mar; 58(3):425. PubMed ID: 12564437 [No Abstract] [Full Text] [Related]
19. Sarcomeric protein mutations in dilated cardiomyopathy. Chang AN; Potter JD Heart Fail Rev; 2005 Sep; 10(3):225-35. PubMed ID: 16416045 [TBL] [Abstract][Full Text] [Related]
20. Adult-onset familial hypertrophic cardiomyopathy caused by a novel mutation, R694C, in the MYH7 gene. Andersen PS; Havndrup O; Bundgaard H; Larsen LA; Vuust J; Kjeldsen K; Christiansen M Clin Genet; 1999 Sep; 56(3):244-6. PubMed ID: 10563488 [No Abstract] [Full Text] [Related] [Next] [New Search]